What is the proper dosage and administration of ergocalciferol (Vitamin D2) 1,250 mcg (50,000 units) capsules for treating vitamin D deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ergocalciferol (Vitamin D2) Dosing for Vitamin D Deficiency Treatment

For treating vitamin D deficiency, ergocalciferol (Vitamin D2) 50,000 IU should be administered once weekly for 8-12 weeks, followed by monthly maintenance dosing of 50,000 IU to maintain adequate vitamin D levels. 1

Dosing Based on Deficiency Severity

  • Severe deficiency (<10 ng/mL): 50,000 IU weekly for 12 weeks, followed by monthly maintenance dosing 1
  • Mild to moderate deficiency (10-20 ng/mL): 50,000 IU weekly for 8 weeks, followed by monthly maintenance 1, 2
  • Insufficiency (20-30 ng/mL): 50,000 IU every other week for 12 weeks 2, 3
  • Maintenance therapy: After achieving target levels (≥30 ng/mL), continue with 50,000 IU monthly 1

Administration Considerations

  • Ergocalciferol capsules should be taken with food to enhance absorption 2
  • Monthly dosing of 50,000 IU achieves the equivalent of approximately 1,600 IU daily 1, 3
  • Ensure adequate calcium intake (1,000-1,500 mg daily) alongside vitamin D supplementation 2, 3
  • For convenience in adults with normal kidney function, one 50,000 IU capsule monthly is appropriate for maintenance therapy 1

Monitoring Recommendations

  • Check serum 25(OH)D levels after 3-6 months of therapy to ensure adequate response 2, 3
  • Target serum 25(OH)D level should be at least 30 ng/mL for optimal bone health and anti-fracture efficacy 2
  • Monitor serum calcium if using high doses for extended periods 1
  • Development of hypercalcemia would indicate excessive dosing 1

Special Populations

  • Chronic kidney disease patients: Ergocalciferol is preferred over cholecalciferol for patients with CKD 1
  • Elderly patients (≥65 years): May require higher maintenance doses due to decreased skin synthesis 2
  • Obese patients: May require higher doses (up to 50,000 IU weekly) for maintenance due to sequestration in adipose tissue 4
  • Patients with malabsorption: May require higher doses or more frequent administration 2, 4

Safety Considerations

  • Ergocalciferol doses of up to 10,000 IU daily have been given to patients with advanced CKD for over a year without evidence of toxicity 1
  • Vitamin D toxicity is rare but can occur with prolonged high doses (typically >10,000 IU daily) 2
  • Calcitriol or other synthetic active vitamin D analogs should not be used to treat vitamin D deficiency 1, 3
  • Case reports show lack of toxicity even with extremely high doses (150,000 IU daily for years), though such doses are not recommended 5

Efficacy of Treatment Regimens

  • Regimens containing at least 600,000 IU of ergocalciferol total dose are most effective in achieving vitamin D sufficiency 6
  • The 50,000 IU three times weekly for 6 weeks regimen achieved sufficiency in 82% of patients in one study 6
  • The response to vitamin D supplementation varies between individuals due to genetic factors and body composition 2, 3

Common Pitfalls to Avoid

  • Not ensuring adequate duration of treatment (minimum 8 weeks for loading dose) 2, 6
  • Failing to transition to maintenance therapy after initial repletion 1, 2
  • Not accounting for individual variability in response to supplementation 2, 3
  • Using single annual high doses which may lead to adverse outcomes 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vitamin D Insufficiency Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vitamin D Supplementation for Deficiency in Adults and Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of vitamin D repletion regimens to correct vitamin D status in adults.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.